News About: Goverment
1 in 100 Koreans has epilepsy
One in 100 Koreans has experienced epilepsy, the Korean Epilepsy Society (KEC) said Thursday.
Epilepsy is a common and diverse set of chronic neurological disorders characterized by seizures.
According to the so...
Court rules against drug price cuts
The Seoul Administrative Court ruled last week that a 20-percent price cut on drugs of Dong-A Pharma and Hutecs Korea could be justified due to insufficient evidencing data.
Turning down a claim from the Ministry o...
Illegal rebate activities in dental industry specified
Starting August 1, offering a dental doctor with money and goods will be considered a rebate activity in the dental trade industry, according to the nation’s antitrust agency.
The Fair Trade Commission (FTC) has re...
Controversy mounts over plan to re-categorize drugs
Tension is escalating between doctors and pharmacists over the government's plan to "re-categorize" medicines as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug us...
Shutdown of discount chains causes troubles to pharmacies
The new parliament is pushing to quickly enact a bill that will reduce business hours for discount store chains and super-supermarkets (SSMs), raising the ire of pharmacies owners.
Under the current law, large stor...
Constitutional court rejects petition by KMA head
The Constitutional Court rejected a petition by Kyung Man-ho, ex-head of the Korea Medical Association (KMA), Thursday, ruling that the current integrated medical insurance is constitutional.
“The national health ...
HIRA to designate hospitals for Soliris
From August 1, the national health insurance will cover Soliris (eculizumab) as a treatment for patients in Korea with paroxysmal nocturnal hemoglobinuria (PNH), the Health Insurance Review and Assessment Service said...
Korea to introduce DRG program from July
Fees for seven different medical treatments including cataract surgeries and caesarean sections will go down by an average of 21 percent from July.
The Health Insurance Policy Review Committee of the Ministry of He...
Local drugmakers to face another government-mandated price cuts
The Korean pharmaceutical industry will be hit with the second price cuts of drugs in the latter half of the year as several companies were found to pay illegal rebate to doctors last year.
In a recent lawsuit, the...
Wyeth’s pneumococcal vaccine OK’d for wider age group
Wyeth Korea said Tuesday that Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved Friday by the Korea Food and Drug Administration for people aged 50 years or older to prevent pneumonia and invasive d...
